HCW Biologics Inc.
HCWB | NASDAQ
$1.91
+$0.04 (+2.14%)
At close: Sep 21, 2026, 4:00 PM ET
$2
+$0.09 (+4.71%)
Pre-market:
Sep 22, 2026, 5:35 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.09 | -23.17 | -70.29 | -182.36 | -257.78 | -1.58K |
PEG Ratio | 0 | -2.32 | -1.05 | -10.94 | -2.06 | 66.15 |
PS Ratio | 37.52 | 269.62 | 622.05 | 408.15 | n/a | 2.26K |
PB Ratio | 0.74 | -102.22 | 131.32 | 73.30 | 64.84 | 642.39 |
P/FCF Ratio | -0.15 | -47.76 | -61.56 | -132.79 | -301.12 | -871.02 |
P/OCF Ratio | -0.15 | -48.64 | -78.52 | -264.16 | -302.42 | -886.61 |
OCF/S Ratio | -24.69K | -554.29 | -792.25 | -154.51 | n/a | -254.44 |
Debt / Equity Ratio | 2.46 | -2.02 | 0.47 | 0.17 | n/a | 0.04 |
Quick Ratio | 0.11 | 0.19 | 0.73 | 11.05 | 17.44 | 12.14 |
Current Ratio | 0.11 | 0.19 | 0.73 | 11.52 | 17.44 | 12.14 |
Asset Turnover | 0 | 0.08 | 0.10 | 0.14 | n/a | 0.27 |
Interest Coverage | -9 | -25.45 | -90.86 | -119.05 | n/a | n/a |
Return on Equity | -287.90% | 443.47% | -185.67% | -39.81% | -25.13% | -40.15% |
Return on Assets | -32.46% | -99.30% | -87.66% | -31.83% | -24.04% | -37.54% |
Return on Invested Capital | -109.65% | -425.86% | -130.11% | -34.39% | -26.11% | -38.92% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 20% | 37.38% | 19.72% | 38.48% | n/a | 100% |
Net Profit Margin | -14.68K% | -1.17K% | -879.52% | -221.67% | n/a | -140.98% |
Pretax Profit Margin | -14.68K% | -1.17K% | -879.52% | -221.67% | n/a | -141.53% |
Operating Profit Margin | -20.76K% | -1.15K% | -904.96% | -224.32% | n/a | -142.07% |
FCF Margin | -24.69K% | -564.48% | -1.01K% | -307.36% | n/a | -258.99% |
EBITDA Margin | -10.45K% | -1.08K% | -829.62% | -209.10% | n/a | -128.10% |
Add to Watchlist
Select watchlists to add or remove HCWB